Morphological identification of right ventricular failure in cases of fatal pulmonary thromboembolism by Fracasso, Tony et al.
ORIGINAL ARTICLE
Morphological identification of right ventricular failure
in cases of fatal pulmonary thromboembolism
Tony Fracasso & Heidi Pfeiffer & Cristina Sauerland &
Andreas Schmeling
Received: 10 June 2010 /Accepted: 28 June 2010 /Published online: 10 July 2010
# Springer-Verlag 2010
Abstract Pulmonary thromboembolism is a life-threatening
event potentially determining right ventricular failure. Even
if the pathophysiology of this phenomenon has been widely
investigated, no morphological demonstration of right
ventricular ischemic damage determining right ventricular
failure in cases of fatal pulmonary embolism has been
reported till now. We performed an immunohistochemical
investigation with the markers fibronectin and C5b-9 in 26
cases of fatal pulmonary thromboembolism (16 ♀, 10 ♂,
mean age 56.4 years), as well as in 25 cases of myocardial
infarction (16♀, 9♂, mean age 60.8 years) and 20 cases of
hanging (3♀, 17♂, mean age 40.8 years). In each case, at
least one tissue slide from both cardiac ventricles (free wall
of the right ventricle, anterior and/or posterior wall of the left
ventricle) was prepared. The reactions were semiquantita-
tively classified and the groups compared. In the study
group, the occurrence of ischemic changes at the right
ventricle was significantly higher than in cases of myocardial
infarction and global hypoxia due to hanging. The determin-
ing aspect of the immunohistochemical examination is the
identification of the prevalent ischemic lesion at the right
ventricle compared to the left one. This may indicate the
primary involvement of the right ventricle thus demonstrat-
ing a right ventricular failure.
Keywords Ischemic damage . Pulmonary
thromboembolism . Acute pulmonary hypertension . Right
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Introduction
The potentially lethal involvement of the right ventricle in
cases of pulmonary thromboembolism (PT) is widely
known [1, 2] and clinically identifiable with common
radiological techniques or biochemical analyses [3–6]. On
the contrary, post-mortem identification of right ventricular
failure is not possible, and the diagnosis of its occurrence is
mostly based on clinical knowledge: pathological signs
such as dilatation of the right ventricle at autopsy have been
repeatedly described [7, 8], but their diagnostic power is
doubtful. Not even histological studies aimed at identifying
right ventricular damage in cases of pulmonary embolism
could demonstrate typical morphological patterns [9–11].
The right ventricular function is commonly compro-
mised when the impedance to right ventricular ejection is
acutely increased. Typical is the case of acute pulmonary
hypertension following severe PT [12]. PT determines
increasing pulmonary pressure in a double way: directly
by obstruction of the lumen, indirectly due to reactive
vasoconstriction following hypoxemia [13, 14]. As a
consequence, the right ventricle reacts with acute dilatation
[15, 16] and increased coronary perfusion [12] with
resulting positive inotropic effect. However, if the pulmo-
nary hypertension persists, these protective mechanisms fail
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and contribute to ischemic damage: the right ventricular
dilatation, in fact, affects the left ventricular diastolic
compliance determining a decrease in the left ventricular
output with subsequently reduced coronary perfusion of the
right ventricle and ischemic damage due to the combination
of lower coronary supply and increased demand for oxygen
[3, 17–19]. Even if this theory is generally accepted,
morphological evidence of ischemic damage is still
missing: Iwadate et al. [7, 11] could not demonstrate
ischemic changes at the right ventricle in cases of PT, but
could observe a tendency to increased macrophage infil-
trates in cases of PT. The variable occurrence of myocar-
ditis/endocarditis at the right and left ventricle in cases of
lethal PT was also observed by Begieneman et al. [20].
We have recently proposed a method [21] that, in cases
of severe pulmonary fat embolism, is able to detect
prevalent ischemic necrosis at the right ventricle compared
to the left. This method is based on the evaluation of the
expression of the immunohistochemical markers fibronectin
and the terminal complement complex C5b-9 in the
myocardium of both ventricles. Fibronectin is a well-
studied glycoprotein present in the extracellular matrix
where it plays a major role in the processes of cell
migration, adhesion and wound healing [22]. In legal
medicine, it has been extensively investigated in the field
of the wound age estimation, with a special application
for the detection of the vitality of skin wounds [23].
Recently, Bohnert et al. [24] have proposed a further
application for the evaluation of vitality in burnt bodies. In
cases of cardiac ischemic damage, fibronectin diffuses into
the necrotic cardiac myocytes where it probably binds to
actin filaments, thus granting tensile strength of the
infarcted ventricle before deposition of new collagen
occurs [25].
The terminal complement complex C5b-9 accumulates
on the surface of damaged cardiac cells and promotes the
formation of pores on the cellular membrane [26]. C5b-9
can be detected if the survival time after onset of the
cardiac ischemia is longer than 30–40 min [27]; the
Table 1 Study group, cases of fatal pulmonary thromboembolism,
(N =26; 16 ♀, 10 ♂, mean age 56.4 years)
ID Sex Age RV
fibronectin
LV
fibronectin
Δ
fibronectin
RV
C5b-9
LV
C5b-9
Δ
C5b-9
1 F 71 3 1 2 2 0 2
2 M 44 3 2 1 0 0 0
3 F 32 2 0 2 0 0 0
4 F 80 3 1 2 1 0 1
5 F 51 2 2 0 0 0 0
6 F 22 2 1 1 0 0 0
7 M 55 2 1 1 1 0 1
8 M 65 3 2 1 0 0 0
9 F 49 3 0 3 0 0 0
10 F 51 3 1 2 0 0 0
11 F 49 3 0 3 1 0 1
12 F 72 2 1 1 1 0 1
13 M 83 2 1 1 0 0 0
14 F 80 3 1 2 0 0 0
15 M 72 3 0 3 0 0 0
16 M 43 3 1 2 0 0 0
17 F 84 3 2 1 0 0 0
18 F 75 3 1 2 0 0 0
19 F 48 2 0 2 2 0 0
20 M 23 3 3 0 1 0 1
21 F 22 2 2 0 2 0 2
22 M 38 3 1 2 0 0 0
23 F 87 2 1 1 0 0 0
24 F 82 2 0 2 0 0 0
25 M 31 2 0 2 0 0 0
26 M 57 2 1 1 0 0 0
Table 2 Cases of heart infarction (N=25, 16♀, 9♂, mean age 60.8 y)
ID Sex Age RV
Fibronectin
LV
Fibronectin
Δ
Fibronectin
RV
C5b-
9
LV
C5b-
9
Δ
C5b-
9
1 F 61 2 2 0 0 2 −2
2 F 40 2 2 0 0 0 0
3 F 41 2 3 −1 0 0 0
4 F 40 2 2 0 0 0 0
5 F 46 1 1 0 0 0 0
6 F 81 2 3 −1 2 2 0
7 M 43 2 2 0 0 0 0
8 F 82 2 2 0 0 0 0
9 F 76 1 2 −1 0 0 0
10 M 67 2 3 −1 0 2 −2
11 M 70 2 3 −1 1 1 0
12 M 66 2 2 0 0 0 0
13 F 53 2 2 0 0 0 0
14 M 38 3 3 0 0 0 0
15 F 58 2 2 0 0 0 0
16 F 87 2 0 2 0 2 −2
17 F 80 2 3 −1 1 1 0
18 F 46 1 1 0 0 0 0
19 M 41 3 3 0 0 2 −2
20 M 60 2 2 0 0 0 0
21 F 41 2 3 −1 0 0 0
22 M 47 1 3 −2 0 2 −2
23 F 88 2 3 −1 0 1 −1
24 F 82 2 2 0 0 0 0
25 M 87 1 3 −2 1 2 −1
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intrasarcolemmal accumulation of fibronectin is detectable
even earlier [28].
The hypothesis at the base of the present study is that
primary right heart ischemia due to pulmonary hyperten-
sion, in cases of PT, can be distinguished from primary
left ventricular failure due to myocardial infarction and
from heart damage due to global hypoxia. The nature of
the myocardial lesions, in cases of acute myocardial
infarction, does not differ from the cardiac damage
following pulmonary embolism, as both are ischemic;
nevertheless, our hypothesis is that from a morphological
point of view they can be distinguished: in cases of
myocardial infarction, the left ventricle is more affected
than the right one because of its major oxygen demand
and the relatively minor functional reserves, if compared
to the right one. For these reasons, the extension and the
localization of the ischemic cardiac damage should allow
a good differentiation between primary lesions following
pulmonary hypertension due to pulmonary embolism
(prevalently localised at the right ventricle) and acute
ischemic damage following acute myocardial infarction
(prevalently localised at the left ventricle or equally
distributed in the myocardium of both ventricles).
Finally, the comparison with a third group (cases of
hanging) is useful to differentiate the pattern of ischemic
lesions from agonal necroses due to terminal global
hypoxia. In this group, fresh cardiac damage should be
less extensive than in cases of ischemia and show a similar
distribution in the two ventricles or a predilection for the
left one.
Materials and methods
Our material constituted of 26 cases of fatal pulmonary
thromboembolism (study group, 16 ♀, 10 ♂, mean age
56.4 years), 25 cases of acute myocardial infarction (group
2, 16♀, 9♂, mean age 60.8 years) and 20 cases of hanging
(group 3, 3♀, 17♂, mean age 40.8 years). All these cases
were collected at the Institute of Legal Medicine of the
University Hospital in Münster and retrospectively investi-
gated. In each case, information about circumstances of
death, as well as autopsy record, was available. An
overview of the investigated cases is given in Tables 1, 2
and 3. In each case, immunohistochemical reactions with
the antibodies fibronectin (Polyclonal Rabbit Anti-Human,
DAKO Deutschland GmbH, Hamburg, Germany) and C5b-
9 (Monoclonal Mouse Anti-Human, DAKO Deutschland
GmbH, Hamburg, Germany) of at least one tissue slide
from both cardiac ventricles (free wall of the right ventricle
(RV), anterior and/or posterior wall of the left ventricle
(LV)) were prepared as described elsewhere [19, 20]. A
blind investigation of the slides was performed by two
different observers with final consensual evaluation. The
positive reactions were semiquantitatively classified as
follows [21]:
Grade 0: negative
Grade 1: single cells necrosis
Grade 2: group cells necrosis
Grade 3: diffuse necrosis
The grade of necrosis in each ventricle for each antibody
in the study group was compared to the corresponding
value of the groups 2 and 3 (grade of necrosis RV
fibronectin study group versus grade of necrosis RV
fibronectin groups 2 and 3; grade of necrosis RV C5b-9
study group versus grade of necrosis RV C5b-9 groups 2
and 3; grade of necrosis LV fibronectin study group versus
grade of necrosis LV fibronectin groups 2 and 3; grade of
necrosis LV C5b-9 study group versus grade of necrosis RV
C5b-9 groups 2 and 3).
The difference of the grade of the necrosis between right
and left ventricle was calculated in each case (Δ = grade
necrosis RV − grade necrosis LV) with both antibodies. A
comparison of these differences between study group and
groups 2 and 3 was performed. Groups 2 and 3 were finally
compared to each other.
Statistical analyses were performed using SAS 9.2 (SAS
Institute Inc., Cary, NC).
Table 3 Cases of hanging (N=20, 3♀, 17♂, mean age 40.8 y)
ID Sex Age RV
fibronectin
LV
fibronectin
Δ
fibronectin
RV
C5b-9
LV
C5b-9
Δ
C5b-9
1 M 42 2 2 0 0 0 0
2 M 44 0 0 0 0 0 0
3 M 56 1 2 −1 0 0 0
4 F 46 0 0 0 0 0 0
5 M 23 0 1 −1 0 0 0
6 M 44 0 0 0 0 0 0
7 M 54 2 2 0 0 0 0
8 F 55 2 2 0 0 0 0
9 F 43 2 2 0 0 0 0
10 M 42 2 2 0 0 0 0
11 M 35 1 1 0 0 0 0
12 M 56 2 2 0 0 0 0
13 M 49 2 2 0 0 0 0
14 M 20 0 1 −1 0 0 0
15 M 35 2 2 0 0 0 0
16 M 21 0 0 0 0 0 0
17 M 40 2 2 0 0 0 0
18 M 41 2 2 0 0 0 0
19 M 38 2 2 0 0 0 0
20 M 31 2 2 0 0 0 0
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Fisher’s exact test was used for all comparisons
between the investigated groups. The result was considered
significant in case of the two-sided p<0.05.
Results
The comparison of the grade of necrosis in the right
ventricle showed a higher expression of the antibody
fibronectin in the study group compared to both cases of
acute myocardial infarctions and hanging (p<0.0001).
Fibronectin was more expressed in the right ventricle in
cases of heart infarction compared to hanging (p<0.01).
The terminal complement portion C5b-9 was more
expressed at the right ventricle in cases of PT compared to
cases of hanging, in which it was never detected (p<0.035). A
similar expression was detected in comparison to myocardial
infarctions.
The comparison of the grade of necrosis in the left
ventricles showed a prevalent involvement of this ventri-
cle in both groups 2 and 3 compared to the study group,
with fibronectin (p<0.0001 and p<0.0059, respectively).
The comparison between groups 2 and 3 showed a higher
expression at the left ventricle in cases of heart infarction
(p<0.0013).
The terminal complement portion C5b-9 was expressed at
the left ventricle only in cases of myocardial infarction. The
differences with the study group and the group hanging are
statistically significant (p<0.001 and p<0.004, respectively).
The comparison of the difference of the grade of the
necrosis between right and left ventricle with the antibody
fibronectin (Δ fibronectin) showed a statistically significant
difference between the study group and both groups 2 and 3
(p<0.0001). Similar was instead the distribution of the Δ
fibronectin between groups 2 and 3.
The comparison of the difference of the grade of the
necrosis between right and left ventricle with the antibody
a
b
Fig. 1 Immunohistochemical reaction with the antiboby fibronectin,
×200. a Massive positive reaction indicating diffuse ischemic damage
at the right ventricle, grade 3. b Same case, negative reaction at the
myocardium of the left ventricle, grade 0. In this case Δ =3
a
b
Fig. 2 Immunohistochemical reaction with the antiboby C5b-9, ×200.
a Positive reaction indicating group cells necrosis at the right
ventricle, grade 2. b Same case, single cells necrosis at the
myocardium of the left ventricle, grade 1. In this case Δ=1
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C5b-9 (Δ C5b-9) showed a statistically significant difference
between the study group and both groups 2 and 3 (p<0.0004
and p<0.347, respectively). This parameter showed a
different distribution also between cases of heart infarction
and hanging (p<0.0123).
Discussion
In this study, we demonstrated the presence of prevalent
ischemic cardiac damage at the right ventricle in cases of
fatal pulmonary thromboembolism compared to cases of
acute myocardial infarction and cases of global hypoxia due
to hanging.
Interestingly, fresh necrosis at the right ventricle was
detected in 100% of the cases of PT and myocardial
infarction, as well as in 70% of the cases of hanging with
the antibody fibronectin. The antibody C5b-9 was
expressed in 27% of the PT cases, in 16% of the group
myocardial infarction and was never expressed in cases of
hanging. Such a difference in the expression of these
markers is not surprising: Fibronectin is considered a
trustful marker for detection of very early cardiac ischemic
necrosis [28], while C5b-9 is known to react later [27, 28].
The weaker reaction of the terminal complement complex
probably depends on the short duration of agony since the
occurrence of the ischemic damage detectable with fibro-
nectin. Clinical experience supports this hypothesis: one of
the most important prognostic parameter in patients with
PT is the elevation of the troponins as early marker of
cardiac ischemic damage: even patients with severe PT
have a good prognosis if troponins are normal at the time of
hospitalisation [29], this phase corresponds to the time in
which the compensative dilatation of the right ventricle is
still effective and ischemia has not yet occurred; on the
other hand, even a moderate rise of the blood troponin level
correlates with short-term poor outcome [30], indicating a
very rapid death, after beginning of the ischemic damage.
This may also be the explanation for the missed detection
of ischemic damage in previous studies where unspecific
signs or late markers of ischemia had been applied [11, 20].
At the light of our results, the described macrophage
activation and the occurrence of myocarditis/endocarditis
[11, 20] may be interpreted as an inflammatory reaction
occurring after non-lethal ischemic damage, possibly in
cases of recurrent transitory PT. These inflammatory
changes may reflect the response to PT-induced ischemic
changes before occurrence of the lethal massive embolism.
For the morphological identification of cardiac ischemia
determining right heart failure, the discriminating element
is the evaluation of the difference between RV and LV. The
simple detection of necrosis in the right ventricle, in fact,
cannot be considered a reliable sign of primary involvement
of the RV as the most common cause of right ventricular
failure is the failure of the left ventricle [31]: in cases of
myocardial infarction with primary involvement of the left
ventricle, fresh cardiac necrosis regularly occurs also at the
right chamber. The comparison between right and left
ventricle is a simple method to verify if necrosis is more
detectable at the right chamber (as in the investigated cases
of PT), at the left ventricle (as in cases of myocardial
infarction) or is homogeneously distributed (as in cases of
hanging). Therefore, we propose that only if the necrosis is
prevalently localised at the RV, one can consider the
primary involvement of the RV in the determination of
death. In other words, if the Δ is bigger than 0, a primary
right ventricular failure can be taken into account (Figs. 1
and 2).
If compared to cases of pulmonary fat embolism [21],
the results of the present study more clearly show the
correlation with the pulmonary embolism and the occur-
rence of ischemic damage at the right ventricle leading to
failure and death.
It can be concluded that the presented method is able to
detect a prevalent ischemic damage at the right ventricle in
cases of fatal PT. In such cases, the cause of death is
attributable to acute right ventricular failure. This study
confirms the efficacy of this method as a tool for the post-
mortem identification of right ventricular failure due to
ischemia in cases of fatal pulmonary embolism.
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